You are here

  • Home
  • Archive
  • Volume 6, Issue 1
  • Inhibition of WEE1 kinase and cell cycle checkpoint activation sensitizes head and neck cancers to natural killer cell therapies

Article info

Article menu

Download PDFPDF

XML
Research Article
Inhibition of WEE1 kinase and cell cycle checkpoint activation sensitizes head and neck cancers to natural killer cell therapies

Authors

  • Jay Friedman Translational Tumor Immunology Program, National Institutes on Deafness and Other Communication Disorders, National Institutes of Health Building 10, Room 7N240C 20892 Bethesda MD USA PubMed articlesGoogle scholar articles
  • Megan Morisada Translational Tumor Immunology Program, National Institutes on Deafness and Other Communication Disorders, National Institutes of Health Building 10, Room 7N240C 20892 Bethesda MD USA PubMed articlesGoogle scholar articles
  • Lillian Sun Translational Tumor Immunology Program, National Institutes on Deafness and Other Communication Disorders, National Institutes of Health Building 10, Room 7N240C 20892 Bethesda MD USA PubMed articlesGoogle scholar articles
  • Ellen C. Moore Translational Tumor Immunology Program, National Institutes on Deafness and Other Communication Disorders, National Institutes of Health Building 10, Room 7N240C 20892 Bethesda MD USA PubMed articlesGoogle scholar articles
  • Michelle Padget Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health Bethesda MD USA PubMed articlesGoogle scholar articles
  • James W. Hodge Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health Bethesda MD USA PubMed articlesGoogle scholar articles
  • Jeffrey Schlom Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health Bethesda MD USA PubMed articlesGoogle scholar articles
  • Sofia R. Gameiro Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health Bethesda MD USA PubMed articlesGoogle scholar articles
  • Clint T. Allen Translational Tumor Immunology Program, National Institutes on Deafness and Other Communication Disorders, National Institutes of Health Building 10, Room 7N240C 20892 Bethesda MD USA Department of Otolaryngology-Head and Neck SurgeryJohns Hopkins School of Medicine Baltimore MD USA PubMed articlesGoogle scholar articles
  1. ↵i 301-827-5620 clint.allen{at}nih.gov
View Full Text

Citation

Friedman J, Morisada M, Sun L, et al
Inhibition of WEE1 kinase and cell cycle checkpoint activation sensitizes head and neck cancers to natural killer cell therapies
Journal for ImmunoTherapy of Cancer 2018;6:59. doi: 10.1186/s40425-018-0374-2

Publication history

  • Received February 6, 2018
  • Accepted June 5, 2018
  • First published June 21, 2018.
Online issue publication 
January 09, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.